p300介导PPAR-γ通过脂质过氧化反应影响糖尿病视网膜病变的机制

doi:10.3969/j.issn.1006-5725.2025.11.006

Abstract

Abstract:

Objective To explore the molecular mechanism of histone acetyltransferase （p300） mediated peroxisome proliferator activated receptor-γ（PPAR-γ） influencing diabetes retinopathy through lipid peroxidation. Methods Diabetes models were established in 65 SD rats by intraperitoneal injection of streptozotocin， and the remaining 10 SD rats were simultaneously intraperitoneally injected with an equal amount of sterile physiological saline and recorded as the normal group. The successfully modeled rats were randomly divided into six groups： p300 upregulated group， p300 downregulated group， PPAR-γ upregulated group， PPAR-γ downregulated group， empty control group， and model group. Except for the normal group and the model group （which were simultaneously injected with an equal amount of sterile physiological saline through vitreous injection）， each group was injected with pcDNA-p300， si-p300， pcDNA PPAR-γ， si-PPAR-γ， and pcDNA adenovirus solution through vitreous injection. Five rats were selected from each group， and Evans blue method was used to detect the degree of damage to the left eye blood retinal barrier. The fully automated biochemical analyzer detects lipids in each group， including triglycerides （TG）， cholesterol （TC）， low-density lipoprotein cholesterol （LDL-C）， high-density lipoprotein cholesterol （HDL-C）， as well as peroxidation reaction indicators such as superoxide dismutase （SOD） activity， malondialdehyde （MDA） content， and reactive oxygen species （ROS） levels. Five rats from each group were selected to take retinal tissue from their right eyes for hematoxylin eosin （HE） staining to observe pathological changes. After the remaining rats in each group were euthanized by decapitation， real time quantitative polymerase chain reaction （RT-qPCR） was used to detect the expressions of p300， PPAR-γ， protein kinase C β （PKC β）， and adaptor protein p66Shc （P66Shc） messenger RNA （mRNA） in the left eye retinal tissues， and Western blot was used to detect the expression of the aforementioned proteins and the phosphorylation level of P66Shc in the retinal tissues of the right eye. Results Compared with the normal group， the Evans blue concentrations， albumin penetrations， serum TG， TC， LDL-C， MDA contents， and ROS levels increased in all other groups， while HDL-C， SOD activity， p300， PPAR-γ， PKC β， P66Shc expressions， and P66Shc phosphorylation levels decreased （P < 0.05）. Compared with the model group， the p300 downregulated group showed a decrease in p300 expression （P < 0.05）， the Evans blue concentration， albumin permeability， serum TG， TC， LDL-C， MDA contents， and ROS levels were all increased in the p300 downregulated group and PPAR-γ downregulated group， while HDL-C and SOD activity， PPAR-γ， PKC β， P66Shc expression， and P66Shc phosphorylation levels were all decreased （P < 0.05）. The p300 upregulated group showed an increase in p300 expression （P < 0.05）， and the Evans blue concentration， albumin permeability， serum TG， TC， LDL-C， MDA contents， and ROS levels all decreased in the p300 upregulated group and PPAR-γ upregulated group， while HDL-C and SOD activity， PPAR-γ， PKC β， P66Shc expressions， and P66Shc phosphorylation levels all increased （P < 0.05）. There were no statistically significant differences in blood retinal barrier damage， lipid and peroxidation indicators， PPAR-γ， PKC β， P66Shc expression， and P66Shc phosphorylation between the p300 downregulated group and PPAR-γ downregulated group， p300 upregulated group and PPAR-γ upregulated group， unloaded control group and model group （P > 0.05）. Normal group rats showed no pathological changes in retinal tissues， while significant pathological changes were observed in the model group and empty control group. Severe pathological changes were observed in the p300 downregulated group and PPAR-γ downregulated group， while slight pathological changes were observed in the p300 upregulated group and PPAR-γ upregulated group. Conclusion Up-regulation of p300 can positively mediate PPAR-γ to control lipid peroxidation and alleviate diabetes retinopathy， while down-regulation of p300 can promote diabetes retinopathy by inhibiting PPAR-γ to activate lipid peroxidation.

Key words: histone acetyltransferase, peroxisome proliferator activated receptor-γ, lipid peroxidation, diabetes retinopathy

CLC Number:

R363.1+4

Li CUI,Feiyan MA. Mechanism of p300 mediated PPAR⁃γ affecting diabetes retinopathy through lipid peroxidation[J]. The Journal of Practical Medicine, 2025, 41(11): 1645-1654.

Figures/Tables 9

Tab.1

Tab.2

Tab.3

Tab.4

Fig.1

Tab. 5

Tab. 6

Fig.2

Fig.3

References 27

1	FUNG T H， PATEL B， WILMOT E G， et al. Diabetic retinopathy for the non-ophthalmologist［J］. Clin Med （Lond）， 2022， 22（2）：112-116. doi:10.7861/clinmed.2021-0792 doi: 10.7861/clinmed.2021-0792
2	LI S， GUO B， JIANG Y， et al. Long-term Exposure to Ambient PM2.5 and Its Components Associated With Diabetes： Evidence From a Large Population-Based Cohort From China［J］. Diabetes Care， 2023， 46（1）：111-119. doi:10.2337/dc22-1585 doi: 10.2337/dc22-1585
3	HOU X， WANG L， ZHU D， et al. Prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes in China［J］. Nat Commun， 2023， 14（1）：4296. doi:10.1038/s41467-023-39864-w doi: 10.1038/s41467-023-39864-w
4	SHABALALA S C， JOHNSON R， BASSON A K， et al. Detrimental Effects of Lipid Peroxidation in Type 2 Diabetes： Exploring the Neutralizing Influence of Antioxidants［J］. Antioxidants （Basel）， 2022， 11（10）：2071. doi:10.3390/antiox11102071 doi: 10.3390/antiox11102071
5	张薇，陈聪. p300介导组蛋白乙酰化修饰下调PPAR-γ致妊娠期糖尿病小鼠子代心肌细胞糖脂代谢紊乱［J］. 中国病理生理杂志， 2017， 33（12）：2222-2226.
6	安娜，郑卫东，杨丽君. PPAR-γ防治糖尿病视网膜病变的作用机制［J］. 海峡科学， 2016， 32（4）：6-8， 30.
7	KU Y H， CHO B J， KIM M J， et al. Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation［J］. BMC Pharmacol Toxicol， 2017， 18（1）：62. doi:10.1186/s40360-017-0169-y doi: 10.1186/s40360-017-0169-y
8	HUANG T S， WU T， WU Y D， et al. Long-term statins administration exacerbates diabetic nephropathy via ectopic fat deposition in diabetic mice［J］. Nat Commun， 2023， 14（1）：390. doi:10.1038/s41467-023-35944-z doi: 10.1038/s41467-023-35944-z
9	戴旭锋，刘晓玲. 大鼠玻璃体内注射二甲基亚砜对视网膜电图的影响［J］. 中华眼视光学与视觉科学杂志， 2007， 9（1）：51-53.
10	张锐，周颖，倪文吉，等. 人工智能视网膜微血管分析在糖尿病并发症中的应用价值［J］. 实用医学杂志， 2024， 40（8）：1142-1147.
11	FERNANDES SILVA L， HOKKANEN J， VANGIPURAPU J， et al. Metabolites as Risk Factors for Diabetic Retinopathy in Patients With Type 2 Diabetes： A 12-Year Follow-up Study［J］. J Clin Endocrinol Metab， 2023， 109（1）：100-106. doi:10.1210/clinem/dgad452 doi: 10.1210/clinem/dgad452
12	CHEN S N， CHEN S J， WU T T， et al. Refining vitrectomy for proliferative diabetic retinopathy［J］. Graefes Arch Clin Exp Ophthalmol， 2023， 261（12）：3659-3670. doi:10.1007/s00417-023-06134-w doi: 10.1007/s00417-023-06134-w
13	STUDNIČKA J， NĚMČANSKÝ J， VYSLOUŽILOVÁ D， et al. Diabetic Retinopathy-Diagnostics and Treatment Guidelines［J］. Cesk Slov Oftalmol， 2023， 79（5）：238-247. doi:10.31348/2023/28 doi: 10.31348/2023/28
14	SOLDO A M， SOLDO I， KARAČIĆ A， et al. Lipid Peroxidation in Obesity： Can Bariatric Surgery Help？［J］. Antioxidants （Basel）， 2022， 11（8）：1537. doi:10.3390/antiox11081537 doi: 10.3390/antiox11081537
15	GAO J， TAO L， JIANG Z. Alleviate oxidative stress in diabetic retinopathy： Antioxidant therapeutic strategies［J］. Redox Rep， 2023， 28（1）：2272386. doi:10.1080/13510002.2023.2272386 doi: 10.1080/13510002.2023.2272386
16	PERDICES L， FUENTES-BROTO L， SEGURA F， et al. Systemic epigallocatechin gallate protects against retinal degeneration and hepatic oxidative stress in the P23H-1 rat［J］. Neural Regen Res， 2022， 17（3）：625-631. doi:10.4103/1673-5374.320990 doi: 10.4103/1673-5374.320990
17	FAN X， XU M， REN Q， et al. Downregulation of fatty acid binding protein 4 alleviates lipid peroxidation and oxidative stress in diabetic retinopathy by regulating peroxisome proliferator-activated receptor γ-mediated ferroptosis［J］. Bioengineered， 2022， 13（4）：10540-10551. doi:10.1080/21655979.2022.2062533 doi: 10.1080/21655979.2022.2062533
18	LIU J， ZHANG Y， SHI D， et al. Vitamin D Alleviates Type 2 Diabetes Mellitus by Mitigating Oxidative Stress-Induced Pancreatic β-Cell Impairment［J］. Exp Clin Endocrinol Diabetes， 2023， 131（12）：656-666. doi:10.1055/a-2191-9969 doi: 10.1055/a-2191-9969
19	STOCKWELL B R. Ferroptosis turns 10： Emerging mechanisms， physiological functions， and therapeutic applications［J］. Cell， 2022， 185（14）：2401-2421. doi:10.1016/j.cell.2022.06.003 doi: 10.1016/j.cell.2022.06.003
20	HSU C G， CHÁVEZ C L， ZHANG C， et al. The lipid peroxidation product 4-hydroxynonenal inhibits NLRP3 inflammasome activation and macrophage pyroptosis［J］. Cell Death Differ， 2022， 29（9）：1790-1803. doi:10.1038/s41418-022-00966-5 doi: 10.1038/s41418-022-00966-5
21	YANG H C， DELEUZE S， ZUO Y， et al. The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury［J］. J Am Soc Nephrol， 2009， 20（11）：2380-8. doi:10.1681/asn.2008111138 doi: 10.1681/asn.2008111138
22	MATTOS R T， BOSCO A A， NOGUEIRA-MACHADO J A. Rosiglitazone， a PPAR-γ agonist， inhibits VEGF secretion by peripheral blood mononuclear cells and ROS production by human leukocytes［J］. Inflamm Res， 2012， 61（1）：37-41. doi:10.1007/s00011-011-0386-6 doi: 10.1007/s00011-011-0386-6
23	蒋玲，廖洪霞，吴燕，等. 过氧化物酶增生体激活受体-γ激动剂对糖尿病大鼠血-视网膜屏障通透性的影响［J］. 眼科研究， 2010， 28（11）：1054-1058.
24	NIU T， SHI X， LIU X， et al. Porous Se@SiO2 nanospheres alleviate diabetic retinopathy by inhibiting excess lipid peroxidation and inflammation［J］. Mol Med， 2024， 30（1）：24. doi:10.1186/s10020-024-00785-z doi: 10.1186/s10020-024-00785-z
25	LIU Q， LIU C Q， YI W Z， et al. Ferroptosis Contributes to Microvascular Dysfunction in Diabetic Retinopathy［J］. Am J Pathol， 2024， 194（6）：1078-1089. doi:10.1016/j.ajpath.2024.01.019 doi: 10.1016/j.ajpath.2024.01.019
26	DONG M， ZHANG Y， CHEN M， et al. ASF1A-dependent P300-mediated histone H3 lysine 18 lactylation promotes atherosclerosis by regulating EndMT［J］. Acta Pharm Sin B， 2024， 14（7）：3027-3048. doi:10.1016/j.apsb.2024.03.008 doi: 10.1016/j.apsb.2024.03.008
27	RIEMANN A， RAUSCHNER M， REIME S， et al. The Role of microRNAs in gene expression and signaling response of tumor cells to an acidic environment［J］. Int J Mol Sci， 2023， 24（23）：16919. doi:10.3390/ijms242316919 doi: 10.3390/ijms242316919

基因	引物序列	扩增产物长度/bp
p300	上游：5′-TCCTATGGGAGAACGGCAGA-3′ 下游：5′-TCCTTTGTCCCCTGAGCTTG-3′	676
PPAR-γ	上游：5′-GCTCAGGGGACAAAGGAAGC-3′ 下游：5′-TCGCTCTCTCGTGGCTAGTA-3′	814
PKCβ	上游：5′-GAAGGCTATAGTCACCTCGGG-3′ 下游：5′-ATGGTAATAATGCGGCCGGT-3′	143
P66Shc	上游：5′-AGGGGACAAAGGAAGCGCA-3′ 下游：5′-GGAACCAGACGCTACGATCA-3′	511
β-actin	上游：5′-GGCTTGCCACTCCCAAAGTA-3′ 下游：5′-TCTGCGCTTCCTTTGTCCCC-3′	302

组别	n	Evans blue浓度/（ng/mg）	白蛋白渗透/（μL血浆*g视网膜湿重wt^-1×hr^-1）
正常组	5	10.15 ± 2.07	6.58 ± 1.03
模型组	5	25.57 ± 3.59^?	14.06 ± 2.51^?
p300上调组	5	18.10 ± 2.35^?&#	10.20 ± 1.89^?&#
p300下调组	5	30.68 ± 4.32^?&#	19.33 ± 3.01^?&#
PPAR-γ上调组	5	18.21 ± 2.37^?&#	10.22 ± 1.91^?&#
PPAR-γ下调组	5	30.71 ± 4.50^?&#	19.40 ± 3.18^?&#
空载对照组	5	25.60 ± 3.66^?	14.20 ± 2.47^?
F值		145.836	158.967
P值		< 0.001	< 0.001

组别	n	TG	TC	LDL-C	HDL-C
正常组	10	1.15 ± 0.21	1.09 ± 0.20	0.20 ± 0.04	1.98 ± 0.31
模型组	10	1.80 ± 0.30^?	1.78 ± 0.29^?	0.63 ± 0.10^?	1.35 ± 0.27^?
p300上调组	10	1.40 ± 0.24^?&#	1.36 ± 0.23^?&#	0.41 ± 0.06^?&#	1.75 ± 0.30^?&#
p300下调组	10	2.05 ± 0.32^?&#	2.08 ± 0.33^?&#	0.89 ± 0.12^?&#	1.11 ± 0.22^?&#
PPAR-γ上调组	10	1.41 ± 0.22^?&#	1.35 ± 0.25^?&#	0.43 ± 0.07^?&#	1.76 ± 0.28^?&#
PPAR-γ下调组	10	2.07 ± 0.31^?&#	2.10 ± 0.34^?&#	0.90 ± 0.11^?&#	1.13 ± 0.24^?&#
空载对照组	10	1.79 ± 0.28^?	1.80 ± 0.31^?	0.62 ± 0.09^?	1.37 ± 0.29^?
F值		112.315	108.743	129.546	138.735
P值		< 0.001	< 0.001	< 0.001	< 0.001

组别	n	SOD活性/（U/mL）	MDA含量/（μmol/L）	ROS水平/（ng/mL）
正常组	10	151.36 ± 12.58	1.52 ± 0.33	6.15 ± 1.12
模型组	10	112.73 ± 11.55^?	3.26 ± 0.61^?	13.43 ± 2.41^?
p300上调组	10	130.07 ± 13.54^?&#	2.57 ± 0.43^?&#	10.14 ± 2.02^?&#
p300下调组	10	90.75 ± 10.13^?&#	4.35 ± 0.74^?&#	16.25 ± 2.73^?&#
PPAR-γ上调组	10	131.26 ± 13.89^?&#	2.59 ± 0.45^?&#	10.07 ± 2.05^?&#
PPAR-γ下调组	10	91.20 ± 10.22^?&#	4.38 ± 0.76^?&#	16.31 ± 2.70^?&#
空载对照组	10	111.86 ± 11.32^?	3.29 ± 0.64^?	13.28 ± 2.27^?
F值		169.706	154.689	141.655
P值		< 0.001	< 0.001	< 0.001

组别	n	p300	PPAR-γ	PKCβ	P66Shc
正常组	5	1.00	1.00	1.00	1.00
模型组	5	0.71 ± 0.12^?	0.65 ± 0.10^?	0.54 ± 0.09^?	0.48 ± 0.07^?
p300上调组	5	0.95 ± 0.14^?&#	0.83 ± 0.12^?&#	0.80 ± 0.11^?&#	0.85 ± 0.12^?&#
p300下调组	5	0.40 ± 0.06^?&#	0.35 ± 0.06^?&#	0.27 ± 0.04^?&#	0.25 ± 0.05^?&#
PPAR-γ上调组	5	0.71 ± 0.10^?#	0.85 ± 0.13^?&#	0.81 ± 0.12^?&#	0.84 ± 0.11^?&#
PPAR-γ下调组	5	0.72 ± 0.11^?#	0.34 ± 0.05^?&#	0.28 ± 0.05^?&#	0.26 ± 0.05^?&#
空载对照组	5	0.70 ± 0.11^?	0.67 ± 0.12^?	0.55 ± 0.08^?	0.46 ± 0.08^?
F值		196.321	201.457	178.310	186.293
P值		< 0.001	< 0.001	< 0.001	< 0.001

Mechanism of p300 mediated PPAR⁃γ affecting diabetes retinopathy through lipid peroxidation

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 9

References 27

Related Articles 3

Recommended Articles

Metrics

Comments

组别	n	p300	PPAR-γ	PKCβ	P66Shc	P66Shc磷酸化水平
正常组	5	1.78 ± 0.33	1.86 ± 0.28	1.92 ± 0.29	1.95 ± 0.34	1.85 ± 0.21
模型组	5	0.45 ± 0.11^?	0.72 ± 0.13^?	0.81 ± 0.12^?	0.88 ± 0.14^?	0.43 ± 0.05^*
p300上调组	5	1.12 ± 0.24^?&#	1.28 ± 0.22^?&#	1.45 ± 0.27^?&#	1.53 ± 0.22^?&#	0.76 ± 0.13^?&#
p300下调组	5	0.18 ± 0.05^?&#	0.47 ± 0.06^?&#	0.60 ± 0.10^?&#	0.61 ± 0.12^?&#	0.15 ± 0.03^?&#
PPAR-γ上调组	5	0.45 ± 0.11^?#	1.30 ± 0.24^?&#	1.43 ± 0.29^?&#	1.51 ± 0.21^?&#	0.78 ± 0.15^?&#
PPAR-γ下调组	5	0.43 ± 0.10^?#	0.46 ± 0.07^?&#	0.61 ± 0.12^?&#	0.59 ± 0.11^?&#	0.15 ± 0.04^?&#
空载对照组	5	0.42 ± 0.12^?	0.70 ± 0.15^?	0.84 ± 0.15^?	0.90 ± 0.16^?	0.22 ± 0.06^?
F值		222.454	218.736	220.915	239.753	241.078
P值		< 0.001	< 0.001	< 0.001	< 0.001	< 0.001

[1]	Rui ZHANG,Ying ZHOU,Wenji NI,Ya HUANG,Dandan LI,Tao JIN,Yong. ZHONG. Application value of artificial intelligence⁃basedretinal microvascular analysis in diagnosis of diabetes complications [J]. The Journal of Practical Medicine, 2024, 40(8): 1142-1147.
[2]	Xiaoyan WANG,Xiaoyi ZOU,Xiang ZHU,Ting WANG,Yetao QIANG,Siyuan ZHOU,Peng ZHANG,Ping ZHANG. Iron overload regulates atherosclerotic activity of foam cells induced by oxLDL [J]. The Journal of Practical Medicine, 2024, 40(3): 295-301.
[3]	LIU Yang, SUN Yue, YANG Anning, LIU Zige, LIU Taiyang, HAO Wei, LIU Yaoyang, WANG Qiushi, LIU Zhihong. Involvement of ferroptosis in atherosclerosis induced by high⁃fat diet in ApoE-/- mouse and formation of ox ⁃LDL ⁃induced foam cell [J]. The Journal of Practical Medicine, 2021, 37(5): 585-590.